Medicus Pharma Ltd.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Medicus Pharma Ltd. is a biotech and life sciences company focused on advancing precision-guided therapeutic assets through clinical development programs. The company’s current portfolio centers on novel treatments in dermatology and oncology, including SkinJect, a localized immuno-oncology product being developed for non-melanoma skin diseases such as basal cell carcinoma and Gorlin syndrome. It is also developing Teverelix, a next-generation GnRH antagonist being studied for prostate cancer, acute urinary retention related to enlarged prostate, and endometriosis. Medicus Pharma Ltd. works as a clinical-stage developer, supporting research, trial activity, and regulatory progress for specialized drug candidates aimed at difficult-to-treat conditions. Headquartered in Canada with operations in the United States, the company plays a focused role in the life sciences market by advancing targeted therapies from development through clinical evaluation.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Dr. Raza Bokhari M.B.A., M.D.
- Employees
- 16
- Headquarters
- West Conshohocken, PA, United States
- Website
- medicuspharma.com